Search

Copyright of Onkologia i Radioterapia is the property of Wydawnictwo SALVE and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The connections between autoimmunization and carcinogenesis have been observed in many patients' cases for numerous years. Various autoimmune diseases precede the diagnosis of neoplasm, however the mechanisms of autoimmunization may also be useful in anti-cancer defence. This review presents the analysis of links between the mentioned processes and their possible application in modern anti-neoplasmatic immunotherapy.

In cancer patients, thrombosis is commonly found complication. There are many established risk factors which may be responsible for thrombosis in this group of patients. Especially the factors connected with treatment and the cancer itself, seem to be significant in the pathogenesis of thromboembolism. On the other hand, the reactions between cancer, hemostasis and immunological system seem to be important in initiation of the thrombotic process. In this review, on the basis of current literature, we have analyzed the relationship between neoplasmatic thrombosis and immunological disorders. The lack of balance between immunological system and haemostasis in neoplasms is the key issue to solve, in order to correct the long term cancer survival.